International Collaboration of Epidemiological Studies of Cervical Cancer

International Collaboration of Epidemiological Studies of Cervical Cancer: A collaborative reanalysis of individual data on 16,563 women with cervical cancer and 33,542 women without cervical cancer from 24 epidemiological studies

Project summary
The Collaborative Group on Epidemiological Studies of Cervical Cancer has brought together and are currently reanalysing individual data from relevant epidemiological studies worldwide, in order to examine the relationship between cervical cancer and different risk factors .


Collaborator Norway
Inger Torhild Gram, Dr. Med., Ph.D, Professor, Institute of Community Medicine, Faculty of Medicine, University of Tromsø, Norway. Phone: +47 77 64 48 16. E-mail: inger.gram@ism.uit.no.

Main collaborators
Cancer Institute (WIA), Chennai, India: T Rajkumar. Cancer Research UK Epidemiology Group, Wolfson Institute of Preventive Medicine, London, UK: J Cuzick. Cancer Research UK Epidemiology Unit, Oxford, UK: P Appleby, V Beral, A Berrington de González, D Bull, J Green. Danish Cancer Society, Copenhagen, Denmark: S Kjaer. Department of Public Health, Oxford, UK: M Vessey. Fred Hutchinson Cancer Research Center, Seattle, Washington, USA: J Daling, M Madeleine, R Ray, D Thomas. Guanacaste Epidemiological Project, San José, Costa Rica: R Herrero. Department of Medical Epidemiology and Biostatistics, Karolinska Institut, Stockholm, Sweden: N Ylitalo. Institut Català d’Oncologia, Barcelona, Spain: X Bosch, X Castellsagué. Institut Nacional de Santé Publique, Algiers, Algeria: D Hammouda. Institute of Cancer Research, Sutton, UK: J Peto. Istituto di Ricerche Farmacologiche ‘Mario Negri’, Milan, Italy: E Negri, G Randi. Instituto Nacional de Enfermedades Neopláscias ‘Dr Eduardo Caceres Grazini’, Lima, Peru: C Santos. International Agency for Research on Cancer, Lyon, France: D Colin, S Franceschi, N Muñoz, M Plummer. Lund University, Mälmo, Sweden: J Dillner, I Silins. Ministere de la Santé Publique et des Affaires Sociales, Bamako, Mali: S Bayo. Ministry of Health, Rabat, Morocco: N Chaouki. Ministry of Health, Asunción, Paraguay: P Rolón. National Cancer Institute, NIH, Bethesda, Maryland, USA: L Brinton, A Hildesheim, J Lacey Jr, M Schiffman. Cancer Epidemiology Research Group, National Health Laboratory Service, Johannesburg, South Africa: L Stein, MI Urban. Royal College of General Practitioners Oral Contraception Study, UK: P Hannaford. Prince of Songkla University, Songkla, Thailand: S Chichareon. The Cancer Council New South Wales, Sydney, Australia: F Sitas. Universidade de São Paolo, Brazil: J Eluf-Neto. University of Milan, Milan, Italy: C La Vecchia. University of Otago, Dunedin, New Zealand: D Skegg. University of Southern California, Los Angeles, California, USA: M Pike, G Ursin. University of the Philippines, Manila, The Philippines: C Ngelangel. World Health Organisation, Geneva, Switzerland: T Farley.

Responsible institution
International Agency for Research on Cancer, 150 cours Albert Thomas
69372 Lyon cedex 08, France. Tel.: +33 (0)4 72 73 84 02. Fax: +33 (0)4 72 73 83 45
E-mail: ice@iarc.fr

Funding
The UNPD/UNFPA/WHO/World Bank Special Program of Research, Development, and Research Training in Human Reproduction, Department of Reproductive Health and Research, WHO, the International Agency for Research on Cancer, and Cancer Research UK. In Norway: the University of Tromsø and the Aakre Foundation for the Fighting of Cancer.

Project period
2002-2007